David Younger
Co-Founder and CEO at A-Alpha Bio
David Younger is the Co-Founder and CEO at A-Alpha Bio, a biotechnology startup. He has expertise in synthetic biology and protein engineering.
IA40 Spotlight: A-Alpha Bio's David Younger on machine learning in biotech, building cross-functional teams
This week on Founded & Funded, Partner Chris Picardo is talking with A-Alpha Bio Co-founder and CEO David Younger for our first Intelligent Application 40 Spotlight episode of 2023. We announced the 2022 IA40 winners in October, and A-Alpha was the first biotech company to make the list, which was no surprise to us. As one of our portfolio companies, we know the work David and his team are doing at the intersections of biological and data/computer sciences will change the world — but having a group of judges agree with us makes us all the more certain. Protein interactions…
Organizations
See all 4-
A-Alpha Bio Executive Officer, Director 2019–present, Co-Founder and CEO 2017–present · current
-
University of Washington Postdoctoral Researcher 2017–2018, Bioengineering Graduate Student 2012–2017 · past
-
Luminex Corporation Engineering Intern 2011 · past
Education
-
University of Washington Doctor of Philosophy (PhD), Bioengineering · 2012–2017
-
Rice University Bachelor of Science; Bachelor of Arts, Bioengineering, Economics · 2007–2012
-
The London School of Economics and Political Science (LSE) Economics · 2009–2010
